Loxicom®   

(meloxicam) 5 mg/mL Solution for Injection 

 

Loxicom® (meloxicam) 5 mg/mL Solution for Injection is indicated for the control of pain and inflammation associated with osteoarthritis in dogs and for the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy and castration when administered prior to surgery in cats. 

Target Species: Dogs and Cats

Product Attributes

  • May be administered in dogs initially as a single IV or SQ dose followed after 24 hours by Loxicom® (meloxicam oral suspension) 1.5 mg/mL

  • Approved for use in cats to control postoperative pain associated with orthopedic surgery, ovariohysterectomy and castration when administered prior to surgery. Administered as a single, one-time SQ dose.

  • Used extensively by DVMs throughout the U.S.

  • Available in both 10 mL and economical 20 mL vials for more savings

  • Compare Loxicom® (meloxicam) Solution for Injection 5 mg/mL versus Metacam® (meloxicam) 5 mg/mL Solution for Injection pricing for significant savings per treatment and improved clinic profit potential

Warning message on using meloxicam in cats

 

Loxicom® (meloxicam) Solution for Injection 5 mg/mL is a non-steroidal anti-inflammatory drug for use by or on the order of a licensed veterinarian. As with other NSAID-class medications, signs of meloxicam intolerance may include appetite loss, vomiting and diarrhea, which could indicate side effects involving the digestive tract, liver or kidneys. Some of these side effects may occur without warning and, in rare situations may be serious, resulting in hospitalization or even death. Observe the dog or cat for signs of potential drug toxicity. If these signs occur, discontinue meloxicam therapy and contact a veterinarian immediately. Loxicom® should be administered to cats only via the subcutaneous (SQ) route. Do not use intravenously (IV) in cats. Concomitant use with other anti-inflammatory drugs, such as NSAIDs or corticosteroids, should be avoided. Do not administer a second dose of meloxicam to cats. Do not follow the single, one-time dose of meloxicam with any other NSAID or with meloxicam oral suspension in cats. Do not use meloxicam in cats with pre-existing renal dysfunction. Refer to the product insert for additional safety information (including warnings, precautions and contraindications) and full directions for use.

  • Active Ingredient(s)

    meloxicam

  • Dosage Form and Description

    Solution for injection: pale yellow

  • Indications

    Dogs: Loxicom® (meloxicam) 5 mg/mL Solution for Injection is indicated in dogs for the control of pain and inflammation associated with osteoarthritis.

    Cats: For the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy and castration when administered prior to surgery. 

  • Dosage and Administration

    Carefully consider the potential benefits and risks of Loxicom® and other treatment options before deciding to use Loxicom®. Use the lowest effective dose for the shortest duration consistent with individual response.

    Dogs: Loxicom® 5 mg/mL Solution for Injection should be administered initially as a single dose at 0.09 mg/lb (0.2 mg/kg) body weight intravenously (IV) or subcutaneously (SQ), followed, after 24 hours, by Loxicom® Oral Suspension at the daily dose of 0.045 mg/lb (0.1 mg/kg) body weight, either mixed with food or placed directly in the mouth.

    Contraindications:
    Dogs with known hypersensitivity to meloxicam should not receive Loxicom® 5mg/mL Solution for Injection. 

    Cats: Administer a single, one-time subcutaneous dose of Loxicom® 5 mg/mL Solution for Injection to cats at a dose of 0.14 mg/lb (0.3 mg/kg) body weight. Use of additional meloxicam or other NSAIDs is contraindicated. (See Contraindications). To ensure accuracy of dosing, the use of a 1 mL graduated syringe is recommended.

    Loxicom Injection Dosing Chart

    Contraindications: Cats with known hypersensitivity to meloxicam should not receive Loxicom® 5 mg/mL Solution for Injection. Additional doses of meloxicam or other NSAIDs in cats are contraindicated, as no safe dosage for repeated NSAID administration has been established (See Animal Safety). Do not use meloxicam in cats with pre-existing renal dysfunction.

    Warnings: Not for use in humans. Keep this and all medications out of reach of children. Consult a physician in case of accidental ingestion by humans. For subcutaneous (SQ) injectable use in cats. Do not use IV in cats.

    Do not administer a second dose of meloxicam

    When administering any NSAID, appropriate laboratory testing to establish hematological and serum biochemical baseline data is recommended prior to use in dogs and cats. All cats should undergo a thorough history and physical examination before administering meloxicam. Do not repeat the single, one-time dose of meloxicam in cats. Owner should be advised to observe their cats for signs of potential drug toxicity.

  • Storage

    Store at controlled room temperature, 68-77°F (20-25°C). Use within 180 days of first puncture and puncture a maximum of 51 times.

© 2023 Norbrook Laboratories Limited. The Norbrook logo and Loxicom are registered trademarks of Norbrook Laboratories Limited. Metacam is a registered trademark of Boehringer Ingelheim Vetmedica, Inc.

Prefer to speak directly to a member of our team?

Norbrook®, Inc.

We are open Mon - Fri 8:00am - 5:00pm CST

Please note: Product information presented on this website is intended only as a brief summary of Norbrook products for your convenience. Not all products or indications are licensed in every country and may be subject to further local variations. For specific product information you should always consult a healthcare professional from your region or visit the local government agency website for the most up to date information. Please see our terms and conditions for further information.